PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway

Published 2019 View Full Article

Authors

Keywords

Interleukin-17, Intervertebral disc degeneration, PPAR-γ, TNF-α, NF-κB pathway, Inflammatory

Journal

INTERNATIONAL IMMUNOPHARMACOLOGY

Volume 72, Issue -, Pages 138-147

Publisher

Elsevier BV

Online

2019-04-11

DOI

10.1016/j.intimp.2019.04.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.